Barnea & Co.
Michael Barnea’s expertise in the field of corporate law provides him with an in-depth understanding of all aspects of mergers and acquisitions, especially when it comes to complex issues relating to cross border transactions. He provides international organizations with legal counsel as to what is required to purchase local Israeli companies and to Israeli companies on how to merge with larger foreign companies. Barnea provides legal consultation to Israeli companies, whose shares are traded on the local Tel Aviv stock exchange and to those traded on the London and NASDAQ stock exchanges, as well as to foreign investors who hold securities in Israeli companies. Michael Barnea also provides full specialized legal counsel to Israel’s kibbutz sector, with special emphasis on the integration of commercial enterprises within the unique fabric of the kibbutz. He currently sits on the management team of Biogencell, an innovative gene therapy company based in Israel.